| Patients |
Age (yr) |
Gender |
Tumor Location |
GTV (cm3) |
ITVall (cm3) |
ITVMIP (cm3) |
ITVAIP (cm3) |
ITV2phases (cm3) |
PVDMIP |
PVDAIP |
PVD2phase |
| 1 |
81 |
male |
LML |
4.82 |
9.23 |
8.49 |
6.81 |
7.55 |
−0.08 |
−0.26 |
−0.18 |
| 2 |
73 |
male |
RML |
4.05 |
9.61 |
8.67 |
6.49 |
4.60 |
−0.10 |
−0.32 |
−0.52 |
| 3 |
75 |
female |
RML |
2.52 |
7.11 |
6.18 |
6.26 |
4.52 |
−0.13 |
−0.12 |
−0.36 |
| 4 |
58 |
female |
RLL |
7.26 |
18.09 |
16.23 |
16.33 |
13.49 |
−0.10 |
−0.10 |
−0.25 |
| 5 |
78 |
male |
RML |
7.84 |
17.59 |
15.08 |
15.74 |
13.09 |
−0.14 |
−0.10 |
−0.26 |
| 6 |
65 |
male |
RML |
7.05 |
15.01 |
14.00 |
13.48 |
11.76 |
−0.07 |
−0.10 |
−0.22 |
| 7 |
52 |
female |
RLL |
7.11 |
25.53 |
22.81 |
22.18 |
19.42 |
−0.11 |
−0.13 |
−0.24 |
| 8 |
59 |
female |
RML |
10.91 |
23.93 |
22.63 |
20.45 |
17.79 |
−0.05 |
−0.15 |
−0.26 |
| 9 |
55 |
female |
RML |
2.59 |
7.26 |
6.75 |
5.88 |
4.89 |
−0.07 |
−0.19 |
−0.33 |
| 10 |
60 |
male |
LML |
4.11 |
13.30 |
12.61 |
11.95 |
11.23 |
−0.05 |
−0.10 |
−0.16 |
| 11 |
83 |
male |
RLL |
4.80 |
18.46 |
16.51 |
16.85 |
14.87 |
−0.11 |
−0.09 |
−0.19 |
| 12 |
52 |
male |
LUL |
6.94 |
21.62 |
20.58 |
19.89 |
17.99 |
−0.05 |
−0.08 |
−0.17 |
| 13 |
47 |
female |
RUL |
3.71 |
9.43 |
8.76 |
8.85 |
7.77 |
−0.07 |
−0.06 |
−0.18 |
| 14 |
75 |
male |
RML |
12.78 |
37.16 |
34.40 |
34.59 |
28.83 |
−0.07 |
−0.07 |
−0.22 |